PharmaLundensis AB (PHAL)

Spotlight
Currency in SEK
0.570
-0.008(-1.38%)
Real-time Data·
PHAL Scorecard
Full Analysis
Stock generally trades with low price volatility
PHAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4710.644
52 wk Range
0.2881.507
Key Statistics
Edit
Bid/Ask
0.484 / 0.57
Prev. Close
0.578
Open
0.576
Day's Range
0.471-0.644
52 wk Range
0.288-1.507
Volume
18.14K
Average Volume (3m)
22.64K
1-Year Change
2.28%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
No news in this category
Looks like there are no results in this news category

PharmaLundensis Company Profile

PharmaLundensis AB operates as a pharmaceutical company. The company develops Iodocarb for treating chronic obstructive pulmonary disease; and treatments for chronic bronchitis and influenza-induced lung failure. It develops EcoFilter, a system that eliminates the release of pharmaceutical drugs and multi-resistant bacteria in hospital wastewater. PharmaLundensis AB was founded in 2006 and is based in Lund, Sweden.

Compare PHAL to Peers and Sector

Metrics to compare
PHAL
Peers
Sector
Relationship
P/E Ratio
−5.0x−5.9x−0.5x
PEG Ratio
−0.33−0.070.00
Price/Book
5.8x3.6x2.6x
Price / LTM Sales
-32.9x2.9x
Upside (Analyst Target)
-148.7%51.4%
Fair Value Upside
Unlock10.2%9.5%Unlock

Earnings

Latest Release
Feb 12, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the PharmaLundensis (PHAL) Stock Price Today?

The PharmaLundensis stock price today is 0.57.

What Stock Exchange Does PharmaLundensis Trade On?

PharmaLundensis is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for PharmaLundensis?

The stock symbol for PharmaLundensis is "PHAL."

What Is the PharmaLundensis Market Cap?

As of today, PharmaLundensis market cap is 30.54M.

What Is PharmaLundensis's Earnings Per Share (TTM)?

The PharmaLundensis EPS (TTM) is -0.08.

From a Technical Analysis Perspective, Is PHAL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.